ライフサイエンスコーパス: blepharospasm

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 m, 4 Meige syndrome, and 26 benign essential blepharospasm.

2 agnosed with paraneoplastic encephalitis and blepharospasm.

3 reducing the likelihood of disorders such as blepharospasm.

4 Results: Of the 74 patients with blepharospasm, 39 (52.7%) used alleviating maneuvers (me

5 ticollis, nine with writer's cramp, two with blepharospasm and 16 healthy control subjects participat

6 r 2013) of 74 patients with benign essential blepharospasm and 56 patients with hemifacial spasm who

7 e the number of injection visits required by blepharospasm and hemifacial spasm patients during their

8 e and type of alleviating maneuvers used for blepharospasm and hemifacial spasm, dystonia severity, a

9 he only permanent, nonsurgical treatment for blepharospasm and hemifacial spasm.

10 t injection into the eyelid for treatment of blepharospasm and hemifacial spasm.

11 ternative treatment option for patients with blepharospasm and hemifacial spasm.

12 nia manifested by involuntary eyelid spasms (blepharospasm) and lower facial and jaw spasms (oromandi

13 cember 1989 for three disorders (strabismus, blepharospasm, and hemifacial spasm), the number of indi

14 transplant characterized by akinetic mutism, blepharospasm, anomic aphasia, and delirium.

15 The second is patients with blepharospasm-associated deformities.

16 ical technique for treating benign essential blepharospasm (BEB) and apraxia of eyelid opening (ALO).

17 n (BoNT) on blink rate (BR) in patients with blepharospasm (BSP) and increased blinking (IB).

18 nnaire designed to identify eye symptoms and Blepharospasm Disability Index (BSDI) before and 1 month

19 ifference, 1 [95% CI, 0-2]; P = .01) and the Blepharospasm Disability Index severity score (median sc

20 neuvers and those who did not, in either the blepharospasm group (150 vs 125 units; Hodges-Lehmann me

21 option for the treatment of focal dystonias: blepharospasm, hemifacial spasm, and apraxia of eyelid o

22 in A is the most commonly used treatment for blepharospasm, hemifacial spasm, and other focal dystoni

23 otrophic lateral sclerosis, benign essential blepharospasm, hemifacial spasm, and Tourette syndrome.

24 clinical triad of epiphora, photophobia, and blepharospasm; increased intraocular pressure; corneal c

25 Although paraneoplastic blepharospasm is rare, it is an important diagnosis to b

26 year-old woman with the rare complication of blepharospasm-like symptoms appearing contralateral to a

27 ne) (n = 13), FHD (n = 15), benign essential blepharospasm (n = 9), cervical dystonia (n = 10) and in

28 Importance: Patients with benign essential blepharospasm or hemifacial spasm are known to use botul

29 f alleviating maneuvers for benign essential blepharospasm or hemifacial spasm correlates with diseas

30 Myectomy remains essential for treating blepharospasm patients and the most common indication is

31 icin injections in reducing muscle spasms in blepharospasm patients but with increased safety to the

32 oses similar to those proposed for the human blepharospasm patients in Phase I and II trials.

33 botulinum toxin treatment for patients with blepharospasm (r = 0.23; P = .049) and patients with hem

34 This is the only case of paraneoplastic blepharospasm that the authors know of that was the resu

35 road array of diseases from benign essential blepharospasm to facial wrinkles.

36 4 [95% CI, 1-7]; P = .01) than patients with blepharospasm who did not use alleviating maneuvers.

37 Patients with blepharospasm who used alleviating maneuvers scored high

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。